Barclays’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Sell
12,512
-98,515
-89% -$2.42M ﹤0.01% 3672
2025
Q4
$3.17M Buy
111,027
+4,949
+5% +$134K ﹤0.01% 2593
2025
Q3
$3.12M Sell
106,078
-230,056
-68% -$6.29M ﹤0.01% 2534
2025
Q2
$9.69M Buy
336,134
+319,463
+1,916% +$9.45M ﹤0.01% 1611
2025
Q1
$583K Sell
16,671
-2,028
-11% -$82.7K ﹤0.01% 3433
2024
Q4
$833K Sell
18,699
-9,558
-34% -$391K ﹤0.01% 3501
2024
Q3
$1.29M Sell
28,257
-41,945
-60% -$1.7M ﹤0.01% 3183
2024
Q2
$2.33M Buy
70,202
+12,104
+21% +$495K ﹤0.01% 2026
2024
Q1
$2.79M Buy
58,098
+15,231
+36% +$888K ﹤0.01% 2292
2023
Q4
$3.16M Buy
42,867
+17,002
+66% +$1.15M ﹤0.01% 2508
2023
Q3
$1.89M Sell
25,865
-6,823
-21% -$545K ﹤0.01% 1938
2023
Q2
$2.71M Buy
32,688
+8,415
+35% +$737K ﹤0.01% 1687
2023
Q1
$2.16M Buy
24,273
+16,668
+219% +$1.45M ﹤0.01% 2138
2022
Q4
$652K Sell
7,605
-24,555
-76% -$2.08M ﹤0.01% 3129
2022
Q3
$2.3M Buy
32,160
+8,637
+37% +$773K ﹤0.01% 1654
2022
Q2
$2.29M Buy
23,523
+14,362
+157% +$1.46M ﹤0.01% 1765
2022
Q1
$1.03M Sell
9,161
-1,838
-17% -$196K ﹤0.01% 2376
2021
Q4
$1.49M Sell
10,999
-12,866
-54% -$1.79M ﹤0.01% 2565
2021
Q3
$3.37M Sell
23,865
-5,529
-19% -$743K ﹤0.01% 1911
2021
Q2
$3.77M Sell
29,394
-5,227
-15% -$615K ﹤0.01% 1762
2021
Q1
$4.43M Buy
34,621
+25,153
+266% +$4.64M ﹤0.01% 1620
2020
Q4
$1.7M Sell
9,468
-45,221
-83% -$10.1M ﹤0.01% 2369
2020
Q3
$12M Buy
54,689
+26,413
+93% +$5.89M 0.01% 955
2020
Q2
$6.33M Buy
28,276
+14,557
+106% +$2.28M ﹤0.01% 1204
2020
Q1
$1.34M Sell
13,719
-34,600
-72% -$2.8M ﹤0.01% 2660
2019
Q4
$3.63M Buy
48,319
+21,665
+81% +$1.4M ﹤0.01% 2361
2019
Q3
$1.64M Buy
26,654
+2,146
+9% +$129K ﹤0.01% 3112
2019
Q2
$1.45M Buy
24,508
+9,643
+65% +$578K ﹤0.01% 3284
2019
Q1
$974K Sell
14,865
-3,121
-17% -$189K ﹤0.01% 3425
2018
Q4
$878K Sell
17,986
-6,324
-26% -$377K ﹤0.01% 3257
2018
Q3
$1.58M Buy
24,310
+21,909
+912% +$1.53M ﹤0.01% 3147
2018
Q2
$160K Sell
2,401
-8,194
-77% -$495K ﹤0.01% 4908
2018
Q1
$548K Buy
10,595
+4,423
+72% +$206K ﹤0.01% 3881
2017
Q4
$267K Buy
6,172
+125
+2% +$5.11K ﹤0.01% 4442
2017
Q3
$265K Sell
6,047
-12,479
-67% -$434K ﹤0.01% 4183
2017
Q2
$503K Sell
18,526
-16,073
-46% -$398K ﹤0.01% 3521
2017
Q1
$784K Buy
34,599
+28,110
+433% +$581K ﹤0.01% 2952
2016
Q4
$139K Sell
6,489
-20,271
-76% -$435K ﹤0.01% 4513
2016
Q3
$591K Buy
26,760
+8,615
+47% +$184K ﹤0.01% 3089
2016
Q2
$324K Sell
18,145
-2,237
-11% -$38.7K ﹤0.01% 3566
2016
Q1
$347K Sell
20,382
-9,578
-32% -$160K ﹤0.01% 3429
2015
Q4
$630K Sell
29,960
-16,452
-35% -$334K ﹤0.01% 3015
2015
Q3
$834K Buy
46,412
+9,429
+25% +$202K ﹤0.01% 2906
2015
Q2
$813K Buy
36,983
+30,403
+462% +$708K ﹤0.01% 3072
2015
Q1
$173K Sell
6,580
-498
-7% -$12.7K ﹤0.01% 4456
2014
Q4
$198K Buy
7,078
+4,690
+196% +$127K ﹤0.01% 4641
2014
Q3
$62K Buy
2,388
+1,881
+371% +$44.9K ﹤0.01% 5700
2014
Q2
$11K Sell
507
-1,105
-69% -$25.4K ﹤0.01% 6790
2014
Q1
$43K Buy
1,612
+935
+138% +$27.3K ﹤0.01% 6121
2013
Q4
$21K Sell
677
-417
-38% -$10.7K ﹤0.01% 6691
2013
Q3
$31K Sell
1,094
-1,332
-55% -$36.4K ﹤0.01% 6320
2013
Q2
$62K Buy
+2,426
New +$56.8K ﹤0.01% 6159

Other funds holding QDEL

Barclays's QDEL Position: Q1 2026 in Review

Barclays reduced its QuidelOrtho (QDEL) stake by 89% in Q1 2026, selling an estimated $2.42M and leaving 12,512 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #3672.

Barclays first reported a position in QDEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q3 2020. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Barclays held 12,512 shares of QuidelOrtho worth $206K as of Q1 2026.
  • Barclays sold 98,515 QuidelOrtho shares in Q1 2026, an estimated $2.42M.
  • QuidelOrtho made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3672 holding.
  • Barclays first reported a position in QuidelOrtho in Q2 2013 and has held it in 52 quarters since.
  • Barclays's QuidelOrtho position peaked at $12M in Q3 2020.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.